Exploration of oncologists' attitudes toward and perceived value of patient-reported outcomes

Quality of Life Research

Volumn 22, Issue 4, 2013, Pages 725-731

  Meldahl, Michael L ^a   Acaster, Sarah ^b   Hayes, Risa P ^a  

^a ELI LILLY AND COMPANY   (United States)

^b ICON PLC   (United Kingdom)

Author keywords

Clinical decision making; Health related quality of life; Oncologists; Patient reported outcomes

Indexed keywords

ADULT; AGED; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; MIDDLE AGED; NEOPLASMS; ONCOLOGY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PHYSICIAN; QUALITATIVE RESEARCH; QUALITY OF LIFE; UNITED STATES; ARTICLE; NEOPLASM;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CHICAGO; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; NEW YORK; PALLIATIVE CARE; PATIENT OUTCOME ASSESSMENT; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; QUALITATIVE RESEARCH; QUALITY OF LIFE;

EID: 84892822562     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-012-0209-4     Document Type: Article

References (16)

1. Lipscomb, J., Gotay, C. C., & Snyder, C. F. (2007). Patientreported outcomes in cancer: A review of recent research and policy initiatives. CA: A Cancer Journal for Clinicians, 57(5), 278-300.
2. McKee, A. E., Farrell, A. T., Pazdur, R., & Woodcock, J. (2010). The role of the US food and drug administration review process: Clinical trial endpoints in oncology. The Oncologist, 15(suppl 1), 13-18.
3. Coons, S. J., Kothari, S., Monz, B. U., & Burke, L. B. (2011). The patient-reported outcome (PRO) consortium: Filling measurement gaps for PRO endpoints to support labeling claims. Clinical Pharmacology and Therapeutics, 90(5), 743-748.
4. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: SAGE Publications, Inc.
5. Muhr, T. (2004) User's Manual for ATLAS.ti 5.0. Berlin: ATLAS.ti Scientific Software Development GmbH.
6. Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570-579.
7. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
8. Karnofsky, D. A., & Burchenal, J. H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In C. M. MacLeod (Ed.), Evaluation of chemotherapeutic agents (pp. 191-205). New York: Columbia University Press.
9. Oken, M. M., Creech, F. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., et al. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5(6), 649-665.
10. Brundage, M., Bass, B., Jolie, R., & Foley, K. (2011). A knowledge translation challenge: Clinical use of quality of life data from cancer clinical trials. Quality of Life Research, 20(7), 979-985.
11. Bezjak, A., Ng, P., Skeel, R., DePetrillo, A. D., Comis, R., & Taylor, K. M. (2001). Oncologists' use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10(1), 1-13.
12. Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., et al. (2006). The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer, 14(10), 988-998.
13. Osoba, D., Bezjak, A., Brundage, M., Zee, B., Tu, D., Pater, J., et al. (2005). Analysis and interpretation of health-related qualityof-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. European Journal of Cancer, 41(2), 280-287.
14. Schünemann, H. J., Akl, E. A., & Guyatt, G. H. (2006). Interpreting the results of patient reported outcome measures in clinical trials: the clinician's perspective. Health and Quality of Life Outcomes, 4, 62.
15. Guyatt, G., & Schunemann, H. (2007). How can quality of life researchers make their work more useful to health workers and their patients? Quality of Life Research, 16(7), 1097-1105.
16. US Food and Drug Administration. (2009). Patient-reported outcome measures: Use in medical product development to support labeling claims. December: Guidance for Industry.